Quest Diagnostics Officer Sells $131K in Stock Under 10b5-1 Plan

Catherine T. Doherty, an Officer at Quest Diagnostics Inc (DGX), filed a Form 144 notice for the sale of 632 shares of Common Stock, with an aggregate market value of approximately $131,285. The shares were acquired on February 23, 2026, through Restricted Stock Vesting. This transaction is scheduled for March 3, 2026, and is executed under a Rule 10b5-1 trading plan adopted on November 14, 2025. Notably, the reporting person has sold significantly larger amounts in the past three months, totaling over $5.6 million in February 2026.